Ensysce Biosciences, Inc. (ENSC) › Operating IncomeEnsysce Biosciences, Inc. (ENSC) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2018: -$959.2K2019: -$3.33M2020: -$1.61M2021: -$19.87M2022: -$24.22M2023: -$10.72M2024: -$6.73M2025: -$10.24M-$10.24M2018Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025-$10.24M-52.2%2024-$6.73M+37.2%2023-$10.72M+55.8%2022-$24.22M-21.9%2021-$19.87M-1131.7%2020-$1.61M+51.5%2019-$3.33M-247.0%2018-$959.2K—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share